Leap Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Leap Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Leap Therapeutics Inc
Rating: 1.02741675
Author: Trendlyne DVM scores

about

Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, a...

0.29 -0.01 (-3.33%)

93.95% Fall from 52W High

518.2K

XNAS Volume

XNAS 03 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

14.7 / 100

Technically Bearish

26.4 / 100

No estimates available

Leap Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Leap Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, a...

93.95% Fall from 52W High

SWOT Analysis

Leap Therapeutics Inc Live Price Chart